Scleroderma citrinum strain:MB1 Genome sequencing and assembly
We present the whole genome de novo sequencing of S. citrinum. The aim of this study is to develop foundational genomic resources for this species that can be used in further researches, providing insights into the genetic basis of its reported medicinal properties as well as serving as a platform to further characterize putative bioactive proteins and secondary metabolite pathway enzymes and as a reference for comparative genomics.